Changes in the biologics pipeline as well as changes in commercialization needs trigger changes in the technologies we use and work flows for cell line development. The use of innovation technologies: Beacon, AMBR systems, Dyna Drive, and MAM allow for faster, more efficient, and regulatory ready cell line and cell culture development. Compared to manual workflows, innovative technologies eliminate a lot of toil and greatly improve the cell line and cell culture development product. At the end of the day, it is issues with cell line, cell culture process, or product quality that can delay commercialization of your product.
Watch this webinar to learn how the practical application of innovative technologies can accelerate cell culture development.
Manager of Scientific & Technical Affairs